ACTIVE PHARMACEUTICAL INGREDIENT MANUFACTURING AND CLINICAL SUPPLY AGREEMENT (RECOMBINANT HUMAN INSULIN)Manufacturing and Supply Agreement • July 14th, 2010 • Oramed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THIS MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”) is entered into as of July 5, 2010 (the “Effective Date”) ORAMED LTD., a company organized under the laws of the State of Israel with principal offices at Hi-Tech Park 2/5 Givat-Ram, PO Box 39098, Jerusalem 91390, Israel (“Buyer”) and SANOFI-AVENTIS DEUTSCHLAND GMBH, a company existing under the laws of Germany, located at Industriepark Hoechst, 65926 Frankfurt am Main, Germany (“SAD”).
